EMA Probe Prompts New Safety Measures For Decades-Old Drug Metamizole

 
• By Neena Brizmohun

The European Medicines Agency’s safety committee has concluded that the benefits of medicines containing metamizole continue to outweigh the risks but that new measures are needed to minimize the serious outcomes of agranulocytosis.

Metamizole has been used for many years in the EU to treat pain and fever • Source: Shutterstock

More from Europe

More from Geography